| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A blood test for Alzheimer's disease: a step forward
|
Parnetti, Lucilla
|
|
|
20 |
9 |
p. 691-693
|
article
|
| 2 |
A call for better training in restless legs syndrome
|
Deerenberg, Charlotte
|
|
|
20 |
9 |
p. 700-701
|
article
|
| 3 |
Amid competing priorities, dementia must not be forgotten
|
The Lancet Neurology,
|
|
|
20 |
9 |
p. 685
|
article
|
| 4 |
A new thrombolytic drug for acute ischaemic stroke
|
Rothwell, Peter M
|
|
|
20 |
9 |
p. 687-689
|
article
|
| 5 |
Asymptomatic carotid stenosis and stroke risk
|
Abbott, Anne
|
|
|
20 |
9 |
p. 698-699
|
article
|
| 6 |
Asymptomatic carotid stenosis and stroke risk – Authors' reply
|
Howard, Dominic P J
|
|
|
20 |
9 |
p. 699
|
article
|
| 7 |
BTK inhibitors as potential therapies for multiple sclerosis
|
Correale, Jorge
|
|
|
20 |
9 |
p. 689-691
|
article
|
| 8 |
Clinical decision making in MOG antibody-associated disease
|
Dale, Russell C
|
|
|
20 |
9 |
p. 695-697
|
article
|
| 9 |
Does technology make us stupid?
|
Ranscombe, Peter
|
|
|
20 |
9 |
p. 708
|
article
|
| 10 |
Emmanuelle Waubant: a most nautical neurologist
|
Burton, Adrian
|
|
|
20 |
9 |
p. 705
|
article
|
| 11 |
Improving access to the outdoors for people with dementia
|
Reali, Eva
|
|
|
20 |
9 |
p. 702-703
|
article
|
| 12 |
Lifeline
|
|
|
|
20 |
9 |
p. 706
|
article
|
| 13 |
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|
Marignier, Romain
|
|
|
20 |
9 |
p. 762-772
|
article
|
| 14 |
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial
|
Gusev, Eugene I
|
|
|
20 |
9 |
p. 721-728
|
article
|
| 15 |
Nursing homes with a difference: the outdoors inside
|
O'Connor, Aine
|
|
|
20 |
9 |
p. 703-704
|
article
|
| 16 |
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
|
Thijssen, Elisabeth H
|
|
|
20 |
9 |
p. 739-752
|
article
|
| 17 |
Post-viral effects of COVID-19 in the olfactory system and their implications
|
Xydakis, Michael S
|
|
|
20 |
9 |
p. 753-761
|
article
|
| 18 |
Purkinje cells and their trees
|
Zoghbi, Huda Y
|
|
|
20 |
9 |
p. 706
|
article
|
| 19 |
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
|
Brown, J William L
|
|
|
20 |
9 |
p. 709-720
|
article
|
| 20 |
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial
|
Reich, Daniel S
|
|
|
20 |
9 |
p. 729-738
|
article
|
| 21 |
Social prescribing for dementia
|
Gallacher, John
|
|
|
20 |
9 |
p. 707-708
|
article
|
| 22 |
The Dementia UK Ecosystem: a call to action
|
Lalli, Giovanna
|
|
|
20 |
9 |
p. 699-700
|
article
|
| 23 |
The mechanisms of smell loss after SARS-CoV-2 infection
|
Doty, Richard L
|
|
|
20 |
9 |
p. 693-695
|
article
|
| 24 |
Trials and tribulations on the path to remyelination
|
Calabresi, Peter A
|
|
|
20 |
9 |
p. 686-687
|
article
|
Journal description